Literature DB >> 24696239

Editorial commentary: Genetics and infectious mononucleosis.

Henry H Balfour1.   

Abstract

Entities:  

Keywords:  Epstein-Barr virus; genetics; infectious mononucleosis; primary EBV infection

Mesh：

Year:  2014        PMID： 24696239      PMCID： PMC4036689          DOI： 10.1093/cid/ciu206

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Evidence of genetic susceptibility to infectious mononucleosis: a twin study.

Authors:  A E Hwang; A S Hamilton; M G Cockburn; R Ambinder; J Zadnick; E E Brown; T M Mack; W Cozen
Journal:  Epidemiol Infect       Date:  2011-12-08       Impact factor: 2.451

2.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

3.  Primary Epstein-Barr virus infection in early childhood.

Authors:  S Krabbe; J Hesse; P Uldall
Journal:  Arch Dis Child       Date:  1981-01       Impact factor: 3.791

4.  Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition.

Authors:  Henry H Balfour; Frangiscos Sifakis; Joseph A Sliman; Jennifer A Knight; David O Schmeling; William Thomas
Journal:  J Infect Dis       Date:  2013-07-18       Impact factor: 5.226

5.  Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students.

Authors:  Henry H Balfour; Oludare A Odumade; David O Schmeling; Beth D Mullan; Julie A Ed; Jennifer A Knight; Heather E Vezina; William Thomas; Kristin A Hogquist
Journal:  J Infect Dis       Date:  2012-10-24       Impact factor: 5.226

6.  Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

Authors:  Etienne M Sokal; Karel Hoppenbrouwers; Corinne Vandermeulen; Michel Moutschen; Philippe Léonard; Andre Moreels; Michèle Haumont; Alex Bollen; Françoise Smets; Martine Denis
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

7.  A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark.

Authors:  Klaus Rostgaard; Jan Wohlfahrt; Henrik Hjalgrim
Journal:  Clin Infect Dis       Date:  2014-04-02       Impact factor: 9.079

8.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.